Rexahn Pharmaceuticals Inc (NYSE American:RNN)

1.65
Delayed Data
As of Apr 20
 0.00 / 0.00%
Today’s Change
1.42
Today|||52-Week Range
4.84
-18.32%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close1.65
Today’s open1.67
Day’s range1.59 - 1.70
Volume204,268
Average volume (3 months)323,939
Market cap$52.7M
Data as of 8:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)-133.33%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.31

Competitors

 Today’s
change
Today’s
% change
AGLEAeglea Bio Therapeut...-0.01-0.13%
NBYNovaBay Pharmaceutic...-0.02-0.48%
--Innovative Pharmaceu...-0.00-4.17%
FLKSFlex Pharma Inc-0.29-5.30%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 14, 2018
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$9.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
President &
Chief Financial Officer
Douglas J. Swirsky
Corporate headquarters
Rockville, Maryland

Forecasts